Search results
MIRA reports promising Ketamir-2 study, eyes FDA submission By Investing.com
Investing.com· 14 hours agoMIRA Pharmaceuticals, Inc. (NASDAQ: MIRA), a company specializing in neurologic and neuropsychiatric...
Bird flu tests are hard to get. How will we know when to sound the alarm?
NBC News via Yahoo News· 12 hours ago“You ran into a testing booth on every other block in Manhattan because companies got $100 every...
How Long Should I Stay on Ozempic For Weight Loss?
MediaFeed via AOL· 4 days agoYou know Ozempic can help with weight loss, but how long can you stay on Ozempic exactly? Unfortunately, there isn’t a solid answer to this question yet.
FDA Approves Almirall's Klisyri® (tirbanibulin) for the Treatment of Actinic Keratosis on Expanded...
Benzinga· 1 day agoOriginal FDA approval (December 2020) now extended to the use of Klisyri on larger areas of the face or scalp (up to 100 cm2) to address more extensive manifestations of actinic keratosis, driving convenience for both
US FDA warns on risks linked to sulfite-containing compounded drugs
Reuters via Yahoo News· 5 days agobreathing difficulty with low blood oxygen, potentially related to sulfite-containing compounded...
FDA Warns Company Making Stem Cell Products for Pets
MedPage Today· 6 days agoFDA has sent a warning letter to a company that makes stem cell and platelet-rich plasma products -- for pets. The agency told Texas-based Safari Stem Cell that statements ...
How to Know When It’s Time to Swap Antihistamines for Allergy Shots
Self via Yahoo News· 14 hours ago(They’re an eye-watering $800 each, and you need at least one or up to three per visit.) Plus,...
Lykos' MDMA treatment rejected by FDA committee, despite being '75% of the way there'
FierceBiotech· 6 days agoLykos Therapeutics’ attempt to get the first ever MDMA treatment approved in post-traumatic stress...
Evolution Optiks secures 510(k) clearance for new eye examination device
Medical Device Network via Yahoo Finance· 6 days agoThis follows the European CE mark obtained in March 2024. The FDA's clearance is based on the...
FDA Panel Rejects MDMA Drug for PTSD
Medscape· 6 days agoA US Food and Drug Administration (FDA) expert panel has found that the benefits of the psychedelic midomafetamine (MDMA) in combination with psychological intervention for ...